Published: 21 November 2019
Committees
Agenda for the 180th meeting of the Medicines Adverse Reactions Committee to be held on Thursday 5 december 2019, at 9 am
1. |
MATTERS OF ADMINISTRATION |
1.1 |
Welcome and apologies |
1.2 |
Minutes and recommendations of the 179th MARC meeting |
1.3 |
Declarations of potential conflicts of interest |
2. |
MATTERS ARISING FROM THE NZ PHARMACOVIGILANCE CENTRE |
2.1 |
CARM quarterly report |
3. |
PHARMACOVIGILANCE REPORTS |
3.1 |
Matters referred to the MARC under section 36 of the Medicines Act 1981 |
3.1.1 None | |
3.2 |
Matters referred to the MARC by Medsafe |
3.2.1 Pholcodine: benefit-risk review | |
3.2.2 Direct oral anticoagulants and the risk of a rebound effect | |
3.2.3 Cyproterone acetate and the risk of hepatic toxicity | |
3.2.4 Potential drug-drug interaction between capecitabine and proton pump inhibitors | |
4. |
MEDSAFE PHARMACOVIGILANCE ACTIVITIES |
4.1 |
Report on standing agenda items |
4.2 |
Medsafe pharmacovigilance activities |
4.3 |
Prescriber Update |
4.4 |
Quarterly summary of recent safety communications |
5. |
OTHER BUSINESS |